{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:24:10Z","timestamp":1792081450279,"version":"4.4.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The Japanese Society for Radiation Oncology (JASTRO) Guidelines for Radiotherapy Treatment Planning have been revised every four years to incorporate the latest findings since the publication of the first edition in 2004. This is a review which presents the 2024 JASTRO Guidelines for radiotherapy treatment planning for esophageal cancer in English. Regarding the treatment of esophageal cancer, various new findings have emerged over the past 4 years, leading to significant updates in the 2020 edition, particularly in the following six areas: (i) additional details on indications for superficial cancer, (ii) inclusion of clinical trial results (JCOG1109) for neoadjuvant chemotherapy and chemoradiotherapy in locally advanced cases in Japan, (iii) updated references on prophylactic lymph node irradiation, (iv) updates on IMRT, (v) revisions in accordance with the 5th edition of the Esophageal Cancer Treatment Guidelines, and (vi) additions of FOLFOX to concurrent chemotherapy regimens.<\/jats:p>","DOI":"10.1093\/jrr\/rraf029","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:24:30Z","timestamp":1748971470000},"page":"354-364","source":"Crossref","is-referenced-by-count":11,"title":["Radiotherapy treatment planning for esophageal cancer: JASTRO guidelines 2024 for radiotherapy treatment planning"],"prefix":"10.1093","volume":"66","author":[{"given":"Keiichi","family":"Jingu","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Tohoku University Graduate School of Medicine , 1-1 Seiryo-chou, Aoba-ku, Sendai, Miyagi, 980-8574 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nihei","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Faculty of Medicine, Osaka Medical and Pharmaceutical University , Osaka , 2-7 Daigakumachi, Takatsuki-shi, Osaka, 569-8686,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Showa University School of Medicine , 1-5-8 Hatanodai, Shinagawa-ku, Tokyo , 142-8666,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Gunma University Graduate School of Medicine , 3-39-22 Showa-machi, Maebashi-shi, Gunma , 371-8511,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Kindai University Faculty of Medicine , 377-2 Ohno-Higashi, Osaka-Sayama, Osaka , 589-8511,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Radiation and Proton Therapy Center, Shizuoka Cancer Center , 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka , 411-8777,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Onozawa","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Funabashi Municipal Medical Center , 1-21-1 Kanasugi, Funabashi-shi, Chiba , 273-8588,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terufumi","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo , 113-8431,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Katoh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Hokkaido University Faculty of Medicine , N15-W7, Kitaku, Sapporo, Hokkaido , 060-868,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuya","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Radiology, Keio University School of Medicine , 35 Shinano, Shinjuku-ku, Tokyo , 160-8582,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Makishima","sequence":"additional","affiliation":[{"name":"QST Hospital, National Institutes for Quantum Science and Technology , 4-9-1 Anagawa, Inage-ku, Chiba , 263-8555,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mayahara","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Kobe Minimally Invasive Cancer Center , 8-5-1 Minatojima-Nakamachi, Chuou-Ku, Kobe, Hyogo , 650-0046,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto , 602-8566,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko Nemoto","family":"Murofushi","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , 3-18-22 Honkomagome, Bunkyo-ku, Tokyo , 113-8677,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Tsujino","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Hyogo Cancer Center , 13-70 Kitaojicho, Akashi-shi, Hyogo , 673-0021,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Igaki","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center Hospital , 5-1-1 Tsukiji, Chuo-ku, Tokyo , 104-0045,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Uno","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University , 1-8-1 Inohana, Chou-ku, Chiba , 260-8677,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"2025072300414452200_ref1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1053\/j.gastro.2022.10.002","article-title":"Final analysis of diagnostic endoscopic resection followed by selective chemoradiotherapy for stage I esophageal cancer: JCOG0508","volume":"164","author":"Nihei","year":"2023","journal-title":"Gastroenterology"},{"key":"2025072300414452200_ref2","doi-asserted-by":"publisher","first-page":"e0271242","DOI":"10.1371\/journal.pone.0271242","article-title":"Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: a meta-analysis","volume":"17","author":"Guo","year":"2022","journal-title":"PLoS One"},{"key":"2025072300414452200_ref3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(24)00745-1","article-title":"Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial","volume":"404","author":"Kato","year":"2024","journal-title":"Lancet"},{"key":"2025072300414452200_ref4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.annonc.2022.10.508","article-title":"Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial","volume":"34","author":"Tang","year":"2023","journal-title":"Ann Oncol"},{"key":"2025072300414452200_ref5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/1471-2407-12-542","article-title":"Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study","volume":"12","author":"Jingu","year":"2012","journal-title":"BMC Cancer"},{"key":"2025072300414452200_ref6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13014-017-0780-5","article-title":"Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients","volume":"12","author":"Yamashita","year":"2017","journal-title":"Radiat Oncol"},{"key":"2025072300414452200_ref7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","article-title":"Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Ajani","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"2025072300414452200_ref8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0360-3016(96)00425-7","article-title":"Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: evaluation by computed tomography and magnetic resonance imaging","volume":"36","author":"Mizowaki","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072300414452200_ref9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00330-017-4935-4","article-title":"Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio","volume":"28","author":"Liu","year":"2018","journal-title":"Eur Radiol"},{"key":"2025072300414452200_ref10","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doad017","article-title":"Stratification of lymph node metastasis improves diagnostic efficiency in thoracic esophageal squamous cell carcinoma","volume":"36","author":"Li","year":"2023","journal-title":"Dis Esophagus"},{"key":"2025072300414452200_ref11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/SLA.0000000000001557","article-title":"The prevalence of overall and initial lymph node metastases in clinical T1N0 thoracic esophageal cancer: from the results of JCOG0502, a prospective multicenter study","volume":"264","author":"Akutsu","year":"2016","journal-title":"Ann Surg"},{"key":"2025072300414452200_ref12","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1200\/JCO.2004.01.083","article-title":"Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer","volume":"22","author":"Westreenen","year":"2004","journal-title":"J Clin Oncol"},{"key":"2025072300414452200_ref13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12149-008-0209-1","article-title":"Integrated FDG-PET\/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer","volume":"23","author":"Okada","year":"2009","journal-title":"Ann Nucl Med"},{"key":"2025072300414452200_ref14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ijrobp.2006.09.015","article-title":"Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma","volume":"67","author":"Gao","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072300414452200_ref15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/jrr\/rry055","article-title":"Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis","volume":"59","author":"Cheng","year":"2018","journal-title":"J Radiat Res"},{"key":"2025072300414452200_ref16","doi-asserted-by":"publisher","first-page":"7460","DOI":"10.1002\/cam4.3409","article-title":"Comparison between the effects of elective nodal irradiation and involved-field irradiation on long-term survival in thoracic esophageal squamous cell carcinoma patients: a prospective, multicenter, randomized, controlled study in China","volume":"9","author":"Lyu","year":"2020","journal-title":"Cancer Med"},{"key":"2025072300414452200_ref17","doi-asserted-by":"publisher","first-page":"1034656","DOI":"10.3389\/fonc.2022.1034656","article-title":"The role of involved field irradiation versus elective nodal irradiation in definitive radiotherapy or chemoradiotherapy for esophageal cancer- a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"2025072300414452200_ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-016-0551-7","article-title":"Japanese classification of esophageal cancer, 11th edition: part I","volume":"14","author":"Society JE","year":"2017","journal-title":"Esophagus"},{"key":"2025072300414452200_ref19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10388-024-01054-y","article-title":"Japanese classification of esophageal cancer, 12th edition: part I","volume":"21","author":"Mine","year":"2024","journal-title":"Esophagus"},{"key":"2025072300414452200_ref20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tipsro.2017.07.002","article-title":"Cone-beam CT-based position verification for oesophageal cancer: evaluation of registration methods and anatomical changes during radiotherapy","volume":"3-4","author":"Nunen","year":"2017","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"2025072300414452200_ref21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijrobp.2007.05.031","article-title":"Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography","volume":"70","author":"Yaremko","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072300414452200_ref22","doi-asserted-by":"publisher","first-page":"e7685","DOI":"10.1097\/MD.0000000000007685","article-title":"Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer: a systematic review and meta-analysis","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2025072300414452200_ref23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.radonc.2020.05.036","article-title":"Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy","volume":"149","author":"Lan","year":"2020","journal-title":"Radiother Oncol"},{"key":"2025072300414452200_ref24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101529","article-title":"Three-dimensional conformal radiotherapy-based or intensity-modulated radiotherapy-based concurrent chemoradiotherapy in patients with thoracic esophageal squamous cell carcinoma","volume":"11","author":"Lin","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2025072300414452200_ref25","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"key":"2025072300414452200_ref26","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ijrobp.2016.08.016","article-title":"Radiation dose escalation in Esophageal cancer revisited: a contemporary analysis of the National Cancer Data Base, 2004 to 2012","volume":"96","author":"Brower","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072300414452200_ref27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.radonc.2016.04.042","article-title":"Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis","volume":"120","author":"Chen","year":"2016","journal-title":"Radiother Oncol"},{"key":"2025072300414452200_ref28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/0284186X.2021.1902564","article-title":"Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG survey","volume":"60","author":"Li","year":"2021","journal-title":"Acta Oncol"},{"key":"2025072300414452200_ref29","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3389\/fonc.2020.01222","article-title":"High vs. low radiation dose of concurrent chemoradiotherapy for esophageal carcinoma with modern radiotherapy techniques: a meta-analysis","volume":"10","author":"Sun","year":"2020","journal-title":"Front Oncol"},{"key":"2025072300414452200_ref30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ijrobp.2022.11.006","article-title":"High-dose versus standard-dose intensity-modulated radiotherapy with concurrent paclitaxel plus carboplatin for patients with thoracic esophageal squamous cell carcinoma: a randomized, multicenter, open-label, phase 3 superiority trial","volume":"115","author":"You","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072300414452200_ref31","doi-asserted-by":"publisher","first-page":"109463","DOI":"10.1016\/j.radonc.2023.109463","article-title":"High versus standard radiation dose of definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis of randomized clinical trials","volume":"180","author":"Wang","year":"2023","journal-title":"Radiother Oncol"},{"key":"2025072300414452200_ref32","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/0360-3016(94)90315-8","article-title":"Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation","volume":"30","author":"Nishimura","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072300414452200_ref33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/ejhf.1376","article-title":"The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer","volume":"21","author":"Mansouri","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2025072300414452200_ref34","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/jrr\/rrad040","article-title":"Clinical impact of radiation-induced myocardial damage detected by cardiac magnetic resonance imaging and dose-volume histogram parameters of the left ventricle as prognostic factors of cardiac events after chemoradiotherapy for esophageal cancer","volume":"64","author":"Umezawa","year":"2023","journal-title":"J Radiat Res"},{"key":"2025072300414452200_ref35","doi-asserted-by":"publisher","first-page":"e2328136","DOI":"10.1001\/jamanetworkopen.2023.28136","article-title":"Efficacy and safety in proton therapy and photon therapy for patients with esophageal cancer: a meta-analysis","volume":"6","author":"Zhou","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025072300414452200_ref36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/cas.12622","article-title":"Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)","volume":"106","author":"Shinoda","year":"2015","journal-title":"Cancer Sci"},{"key":"2025072300414452200_ref37","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ijrobp.2014.03.030","article-title":"Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2)","volume":"89","author":"Higuchi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072300414452200_ref38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol"},{"key":"2025072300414452200_ref39","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1053\/j.gastro.2019.04.017","article-title":"Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma","volume":"157","author":"Minashi","year":"2019","journal-title":"Gastroenterology"},{"key":"2025072300414452200_ref40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10147-015-0872-x","article-title":"Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese radiation oncology study group (JROSG)","volume":"21","author":"Nishimura","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"2025072300414452200_ref41","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/jjco\/hyp069","article-title":"A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan clinical oncology group study (JCOG9708)","volume":"39","author":"Kato","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"2025072300414452200_ref42","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1053\/j.gastro.2021.08.007","article-title":"Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma","volume":"161","author":"Kato","year":"2021","journal-title":"Gastroenterology"},{"key":"2025072300414452200_ref43","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ijrobp.2022.07.007","article-title":"A single-arm confirmatory study of definitive Chemoradiation therapy including salvage treatment for clinical stage II\/III esophageal squamous cell carcinoma (JCOG0909 study)","volume":"114","author":"Takeuchi","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072300414452200_ref44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1245\/s10434-019-07654-8","article-title":"A 3-year overall survival update from a phase 2 study of chemoselection with DCF and subsequent conversion surgery for locally advanced unresectable esophageal cancer","volume":"27","author":"Yokota","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2025072300414452200_ref45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.radonc.2021.11.016","article-title":"Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection","volume":"166","author":"Nishibuchi","year":"2022","journal-title":"Radiother Oncol"},{"key":"2025072300414452200_ref46","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ijrobp.2017.06.2457","article-title":"Toxicity and outcomes in patients with and without Esophageal stents in locally advanced esophageal cancer","volume":"99","author":"Francis","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025072300414452200_ref47","doi-asserted-by":"publisher","first-page":"986828","DOI":"10.3389\/fonc.2022.986828","article-title":"Palliative radiotherapy combined with stent insertion to relieve dysphagia in advanced esophageal carcinoma patients: a systematic review and meta-analysis","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"2025072300414452200_ref48","doi-asserted-by":"publisher","first-page":"1039020","DOI":"10.3389\/fimmu.2022.1039020","article-title":"Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: a meta-analysis and systematic review","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"2025072300414452200_ref49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10388-023-00993-2","article-title":"Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1","volume":"20","author":"Kitagawa","year":"2023","journal-title":"Esophagus"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/66\/4\/354\/63428775\/rraf029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/66\/4\/354\/63428775\/rraf029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:41:50Z","timestamp":1753245710000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/66\/4\/354\/8156060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,6,3]]},"published-print":{"date-parts":[[2025,7,22]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rraf029","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,6,3]]}}}